# Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations

> **NCT01865500** · PHASE4 · COMPLETED · sponsor: **Ataturk University** · enrollment: 100 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Budesonide 4 mg
- **DRUG:** Budesonide 8 mg
- **DRUG:** Metil prednisolone

## Key facts

- **NCT ID:** NCT01865500
- **Lead sponsor:** Ataturk University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2013-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01865500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01865500, "Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT01865500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*